Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04441138
Title Chemoradiation Followed by Durvalumab in Poor Risk and/or Elderly Patients With Stage III NSCLC (ESR1814205)
Acronym ESR1814205
Recruitment Suspended
Gender both
Phase Phase II
Variant Requirements No
Sponsors Rush University Medical Center
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Rush University Cancer Center Chicago Illinois 60612 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field